ROMOSOZUMAB vs ROSUVASTATIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROMOSOZUMAB vs ROSUVASTATIN: Safety Overview
| Metric | ROMOSOZUMAB | ROSUVASTATIN |
|---|---|---|
| Total FAERS Reports | 434 | 36,332 |
| Deaths Reported | 48 | 1,536 |
| Death Rate | 11.1% | 4.2% |
| Hospitalizations | 81 | 11,195 |
| Average Patient Age | 69.1 yrs | 66.1 yrs |
| % Female Patients | 94.5% | 54.9% |
| FDA Approval Date | N/A | Apr 1, 2020 |
| Manufacturer | Amgen, Inc | Umedica Laboratories USA Inc. |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | N/A | Prescription |